Dexamethasone facilitates erythropoiesis in murine embryonic stem cells differentiating into hematopoietic cells in vitro

Biochemical and Biophysical Research Communications

Volumn 346, Issue 2, 2006, Pages 508-516

  Srivastava, Anand S ^a   Kaushal, Sharmeela ^a   Mishra, Rangnath ^b   Lane, Thomas A ^a   Carrier, Ewa ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Erythropoiesis; ES cells; Hematopoiesis; HES; In vitro differentiation

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; CELL NUCLEUS RECEPTOR; CYTOKINE; DEXAMETHASONE; GAMMA GLOBIN; GROWTH FACTOR; HOX PROTEIN; INTERLEUKIN 3; INTERLEUKIN 6; METHYLCELLULOSE; RNA; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 3; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EMBRYO CULTURE; EMBRYONIC STEM CELL; ERYTHROPOIESIS; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE ISOLATION; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA; DEXAMETHASONE; EMBRYO; ERYTHROPOIESIS; ERYTHROPOIETIN; GLUCOCORTICOIDS; HEMATOPOIETIC STEM CELLS; MICE; PLURIPOTENT STEM CELLS; STEM CELL FACTOR;

MURINAE;

EID: 33745128352     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.130     Document Type: Article

References (74)

1. Wobus A.M., Wallukat G., and Hescheler J. Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation 48 (1991) 173-182
2. Rohwedel J., Guan K., Zuschratter W., Jin S., Ahnert-Hilger G., Furst D., Fassler R., and Wobus A.M. Loss of beta1 integrin function results in a retardation of myogenic, but an acceleration of neuronal, differentiation of embryonic stem cells in vitro. Dev. Biol. 201 (1998) 167-184
3. Ziegler B.L., Valtieri M., Porada G.A., De Maria R., Muller R., Masella B., Gabbianelli M., Casella I., Pelosi E., Bock T., Zanjani E.D., and Peschle C. KDR receptor: a key marker defining hematopoietic stem cells. Science 285 (1999) 1553-1558
4. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., Livne E., Binah O., Itskovitz-Eldor J., and Gepstein L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108 (2001) 407-414
5. Rolletschek A., Blyszczuk P., and Wobus A.M. Embryonic stem cell-derived cardiac, neuronal and pancreatic cells as model systems to study toxicological effects. Toxicol. Lett. 149 (2004) 361-369
6. Bain G., Kitchens D., Yao M., Huettner J.E., and Gottlieb D.I. Embryonic stem cells express neuronal properties in vitro. Dev. Biol. 168 (1995) 342-357
7. Okabe S., Forsberg-Nilsson K., Spiro A.C., Segal M., and McKay R.D. Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mech. Dev. 59 (1996) 89-102
8. Kim D.W. Efficient induction of dopaminergic neurons from embryonic stem cells for application to Parkinson's disease. Yonsei Med. J. 45 Suppl. (2004) 23-27
9. Meyers C. Cruel choices: autonomy and critical care decision-making. Bioethics 18 (2004) 104-119
10. Nakayama T., Momoki-Soga T., Yamaguchi K., and Inoue N. Efficient production of neural stem cells and neurons from embryonic stem cells. Neuroreport 15 (2004) 487-491
11. Schmitt R.M., Bruyns E., and Snodgrass H.R. Hematopoietic development of embryonic stem cells in vitro: cytokine and receptor gene expression. Genes Dev. 5 (1991) 728-740
12. Wiles M.V., and Keller G. Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development 111 (1991) 259-267
13. Cho S.K., Webber T.D., Carlyle J.R., Nakano T., Lewis S.M., and Zuniga-Pflucker J.C. Functional characterization of B lymphocytes generated in vitro from embryonic stem cells. Proc. Natl. Acad. Sci. USA 96 (1999) 9797-9802
14. Robertson S.M., Kennedy M., Shannon J.M., and Keller G. A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1. Development 127 (2000) 2447-2459
15. Kubo A., Shinozaki K., Shannon J.M., Kouskoff V., Kennedy M., Woo S., Fehling H.J., and Keller G. Development of definitive endoderm from embryonic stem cells in culture. Development 131 (2004) 1651-1662
16. Drab M., Haller H., Bychkov R., Erdmann B., Lindschau C., Haase H., Morano I., Luft F.C., and Wobus A.M. From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: a retinoic acid and db-cAMP in vitro differentiation model. FASEB J. 11 (1997) 905-915
17. Sone M., Itoh H., Yamashita J., Yurugi-Kobayashi T., Suzuki Y., Kondo Y., Nonoguchi A., Sawada N., Yamahara K., Miyashita K., Park K., Shibuya M., Nito S., Nishikawa S., and Nakao K. Different differentiation kinetics of vascular progenitor cells in primate and mouse embryonic stem cells. Circulation 107 (2003) 2085-2088
18. Wartenberg M., Gunther J., Hescheler J., and Sauer H. The embryoid body as a novel in vitro assay system for antiangiogenic agents. Lab. Invest. 78 (1998) 1301-1314
19. Keijzer R., van Tuyl M., Meijers C., Post M., Tibboel D., Grosveld F., and Koutsourakis M. The transcription factor GATA6 is essential for branching morphogenesis and epithelial cell differentiation during fetal pulmonary development. Development 128 (2001) 503-511
20. Dani C. Embryonic stem cell-derived adipogenesis. Cells Tissues Organs 165 (1999) 173-180
21. Bost F., Caron L., Marchetti I., Dani C., Marchand-Brustel Y., and Binetruy B. Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage. Biochem. J. 361 (2002) 621-627
22. Kramer J., Hegert C., Guan K., Wobus A.M., Muller P.K., and Rohwedel J. Embryonic stem cell-derived chondrogenic differentiation in vitro: activation by BMP-2 and BMP-4. Mech. Dev. 92 (2000) 193-205
23. Wessely O., Deiner E.M., Beug H., and von Lindern M. The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors. EMBO J. 16 (1997) 267-280
24. Park C., Afrikanova I., Chung Y.S., Zhang W.J., Arentson E., Fong G.G., Rosendahl A., and Choi K. A hierarchical order of factors in the generation of. Development 131 (2004) 2749-2762
25. Suwabe N., Takahashi S., Nakano T., and Yamamoto M. GATA-1 regulates growth and differentiation of definitive erythroid lineage cells during in vitro ES cell differentiation. Blood 92 (1998) 4108-4118
26. Pan X., Ohneda O., Ohneda K., Lindeboom F., Iwata F., Shimizu R., Nagano M., Suwabe N., Philipsen S., Lim K.C., Engel J.D., and Yamamoto M. Graded levels of GATA-1 expression modulate survival, proliferation, and differentiation of erythroid progenitors. J. Biol. Chem. 280 (2005) 22385-22394
27. Reya T. Regulation of hematopoietic stem cell self-renewal. Recent Prog. Horm. Res. 58 (2003) 283-295
28. Ting C.N., Olson M.C., Barton K.P., and Leiden J.M. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 384 (1996) 474-478
29. Beato M., Herrlich P., and Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell 83 (1995) 851-857
30. Cole T.J., Blendy J.A., Monaghan A.P., Krieglstein K., Schmid W., Aguzzi A., Fantuzzi G., Hummler E., Unsicker K., and Schutz G. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9 (1995) 1608-1621
31. Tronche F., Kellendonk C., Reichardt H.M., and Schutz G. Genetic dissection of glucocorticoid receptor function in mice. Curr. Opin. Genet. Dev. 8 (1998) 532-538
32. von Lindern M., Deiner E.M., Dolznig H., Parren-Van Amelsvoort M., Hayman M.J., Mullner E.W., and Beug H. Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis. Oncogene 20 (2001) 3651-3664
33. Wessely O., Bauer A., Quang C.T., Deiner E.M., von Lindern M., Mellitzer G., Steinlein P., Ghysdael J., and Beug H. A novel way to induce erythroid progenitor self renewal: cooperation of c-Kit with the erythropoietin receptor. Biol. Chem. 380 (1999) 187-202
34. Reichardt H.M., Kaestner K.H., Tuckermann J., Kretz O., Wessely O., Bock R., Gass P., Schmid W., Herrlich P., Angel P., and Schutz G. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93 (1998) 531-541
35. von Lindern M., Zauner W., Mellitzer G., Steinlein P., Fritsch G., Huber K., Lowenberg B., and Beug H. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood 94 (1999) 550-559
36. Bauer A., Tronche F., Wessely O., Kellendonk C., Reichardt H.M., Steinlein P., Schutz G., and Beug H. The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev. 13 (1999) 2996-3002
37. Leberbauer C., Boulme F., Unfried G., Huber J., Beug H., and Mullner E.W. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood 105 (2005) 85-94
38. Zhou Q., Jouneau A., Brochard V., Adenot P., and Renard J.P. Developmental potential of mouse embryos reconstructed from metaphase embryonic stem cell nuclei. Biol. Reprod. 65 (2001) 412-419
39. Chang T.J., Scher B.M., Waxman S., and Scher W. Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation. Mol. Endocrinol. 7 (1993) 528-542
40. Keller G.M. In vitro differentiation of embryonic stem cells. Curr. Opin. Cell Biol. 7 (1995) 862-869
41. Keller G., Kennedy M., Papayannopoulou T., and Wiles M.V. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol. Cell. Biol. 13 (1993) 473-486
42. Nakano T., Kodama H., and Honjo T. In vitro development of primitive and definitive erythrocytes from different precursors. Science 272 (1996) 722-724
43. Yuen D., Mittal L., Deng C.X., and Choi K. Generation of a primitive erythroid cell line and promotion of its growth by basic fibroblast growth factor. Blood 91 (1998) 3202-3209
44. Garrington T.P., Ishizuka T., Papst P.J., Chayama K., Webb S., Yujiri T., Sun W., Sather S., Russell D.M., Gibson S.B., Keller G., Gelfand E.W., and Johnson G.L. MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells. EMBO J. 19 (2000) 5387-5395
45. Carotta S., Pilat S., Mairhofer A., Schmidt U., Dolznig H., Steinlein P., and Beug H. Directed differentiation and mass cultivation of pure erythroid progenitors from mouse embryonic stem cells. Blood 104 (2004) 1873-1880
46. Fujimoto T.T., Kohata S., Suzuki H., Miyazaki H., and Fujimura K. Production of functional platelets by differentiated embryonic stem (ES) cells in vitro. Blood 102 (2003) 4044-4051
47. Hadjantonakis A.K., Gertsenstein M., Ikawa M., Okabe M., and Nagy A. Generating green fluorescent mice by germline transmission of green fluorescent ES cells. Mech. Dev. 76 (1998) 79-90
48. Dolznig H., Boulme F., Stangl K., Deiner E.M., Mikulits W., Beug H., and Mullner E.W. Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arrays. FASEB J. 15 (2001) 1442-1444
49. Feng Z., Srivastava A.S., Mishra R., and Carrier E. A regulatory role of Wnt signaling pathway in the hematopoietic differentiation of murine embryonic stem cells. Biochem. Biophys. Res. Commun. 324 (2004) 1333-1339
50. Nakano T., Era T., Takahashi T., Kodama H., and Honjo T. Development of erythroid cells from mouse embryonic stem cells in culture: potential use for erythroid transcription factor study. Leukemia 11 Suppl. 3 (1997) 496-500
51. Weiss M.J., Yu C., and Orkin S.H. Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line. Mol. Cell. Biol. 17 (1997) 1642-1651
52. Keller G., Wall C., Fong A.Z., Hawley T.S., and Hawley R.G. Overexpression of HOX11 leads to the immortalization of embryonic precursors with both primitive and definitive hematopoietic potential. Blood 92 (1998) 877-887
53. Kolbus A., Blazquez-Domingo M., Carotta S., Bakker W., Luedemann S., von Lindern M., Steinlein P., and Beug H. Cooperative signaling between cytokine receptors and the glucocorticoid receptor in the expansion of erythroid progenitors: molecular analysis by expression profiling. Blood 102 (2003) 3136-3146
54. Zermati Y., Fichelson S., Valensi F., Freyssinier J.M., Rouyer-Fessard P., Cramer E., Guichard J., Varet B., and Hermine O. Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors. Exp. Hematol. 28 (2000) 885-894
55. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., and Schuh A.C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376 (1995) 62-66
56. Shalaby F., Ho J., Stanford W.L., Fischer K.D., Schuh A.C., Schwartz L., Bernstein A., and Rossant J. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89 (1997) 981-990
57. Schuh A.C., Faloon P., Hu Q.L., Bhimani M., and Choi K. In vitro hematopoietic and endothelial potential of flk-1(-/-) embryonic stem cells and embryos. Proc. Natl. Acad. Sci. USA 96 (1999) 2159-2164
58. Hidaka M., Stanford W.L., and Bernstein A. Conditional requirement for the Flk-1 receptor in the in vitro generation of early hematopoietic cells. Proc. Natl. Acad. Sci. USA 96 (1999) 7370-7375
59. Cerdan C., Rouleau A., and Bhatia M. VEGF-A165 augments erythropoietic development from human embryonic stem cells. Blood 103 (2004) 2504-2512
60. Martin R., Lahlil R., Damert A., Miquerol L., Nagy A., Keller G., and Hoang T. SCL interacts with VEGF to suppress apoptosis at the onset of hematopoiesis. Development 131 (2004) 693-702
61. Umeda K., Heike T., Yoshimoto M., Shiota M., Suemori H., Luo H.Y., Chui D.H., Torii R., Shibuya M., Nakatsuji N., and Nakahata T. Development of primitive and definitive hematopoiesis from nonhuman primate embryonic stem cells in vitro. Development 131 (2004) 1869-1879
62. Tordjman R., Delaire S., Plouet J., Ting S., Gaulard P., Fichelson S., Romeo P.H., and Lemarchandel V. Erythroblasts are a source of angiogenic factors. Blood 97 (2001) 1968-1974
63. Galanello R., Barella S., Turco M.P., Giagu N., Cao A., Dore F., Liberato N.L., Guarnone R., and Barosi G. Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin beta-thalassemia intermedia patients. Blood 83 (1994) 561-565
64. Peschle C., Migliaccio A.R., Migliaccio G., Russo G., Mastroberardino G., Ottolenghi S., Giglioni B., Comi P., Gianni A.M., and Presta M. Cellular and molecular mechanisms of the human embryonic leads to fetal hemoglobin switch. Prog. Clin. Biol. Res. 134 (1983) 411-419
65. Alter B.P., Rappeport J.M., Huisman T.H., Schroeder W.A., and Nathan D.G. Fetal erythropoiesis following bone marrow transplantation. Blood 48 (1976) 843-853
66. Gabbianelli M., Testa U., Massa A., Pelosi E., Sposi N.M., Riccioni R., Luchetti L., and Peschle C. Hemoglobin switching in unicellular erythroid culture of sibling erythroid burst-forming units: kit ligand induces a dose-dependent fetal hemoglobin reactivation potentiated by sodium butyrate. Blood 95 (2000) 3555-3561
67. Peschle C., Gabbianelli M., Testa U., Pelosi E., Barberi T., Fossati C., Valtieri M., and Leone L. c-kit ligand reactivates fetal hemoglobin synthesis in serum-free culture of stringently purified normal adult burst-forming unit-erythroid. Blood 81 (1993) 328-336
68. Roodman G.D., Lee J., and Gidari A.S. Effects of dexamethasone on erythroid colony and burst formation from human fetal liver and adult marrow. Br. J Haematol. 53 (1983) 621-628
69. von Lindern M., Zauner W., Mellitzer G., Steinlein P., Fritsch G., Huber K., Lowenberg B., and Beug H. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood 94 (1999) 550-559
70. De Maria R., Zeuner A., Eramo A., Domenichelli C., Bonci D., Grignani F., Srinivasula S.M., Alnemri E.S., Testa U., and Peschle C. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 401 (1999) 489-493
71. Cantor A.B., and Orkin S.H. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene 21 (2002) 3368-3376
72. Sposi N.M., Zon L.I., Care A., Valtieri M., Testa U., Gabbianelli M., Mariani G., Bottero L., Mather C., and Orkin S.H. Cell cycle-dependent initiation and lineage-dependent abrogation of GATA-1 expression in pure differentiating hematopoietic progenitors. Proc. Natl. Acad. Sci. USA 89 (1992) 6353-6357
73. Condorelli G., Vitelli L., Valtieri M., Marta I., Montesoro E., Lulli V., Baer R., and Peschle C. Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation. Blood 86 (1995) 164-175
74. Lecuyer E., Herblot S., Saint-Denis M., Martin R., Begley C.G., Porcher C., Orkin S.H., and Hoang T. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1. Blood 100 (2002) 2430-2440